Pay in 4 interest-free payments of $5.41 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
In the dose-finding phase 2 trial, the hemoglobin A1c (HbA1c) reduction from baseline to 26 weeks was 0.7% to 1.9% with varying doses of oral semaglutide (2.5 to 40 mg once-daily), 0.3% with placebo, and 1.9% with 1 mg of once-weekly subcutaneous semaglutide [20]
Spectra data were log-transformed and weighted by an adaptive intensity weighting algorithm
When combined with a healthy diet and regular exercise, Semaglutide can be highly effective in helping individuals lose weight
By the time menopause kicked in, Gales was prediabetic and medically obese
Week 25 to 52: Long-term phase
Research shows semaglutide significantly reduces waist circumference and waist-to-height ratio, indicating meaningful abdominal fat loss
US$ 21.19
US$ 27.35
US$ 29.47
US$ 27.84
US$ 26.87
